Phosphorylation-Dependent Interaction of SATB1 and PIAS1 Directs SUMO-Regulated Caspase Cleavage of SATB1

被引:32
|
作者
Tan, Joseph-Anthony T. [1 ]
Song, Jing [1 ]
Chen, Yuan [1 ]
Durrin, Linda K. [1 ]
机构
[1] City Hope Med Ctr, Beckman Res Inst, Div Mol Med, Duarte, CA 91010 USA
关键词
MATRIX ATTACHMENT REGION; DOMAIN-MEDIATED DIMERIZATION; TRANSCRIPTION FACTOR SATB1; BINDING PROTEIN SATB1; TUMOR-SUPPRESSOR P53; DNA-BINDING; GENE-EXPRESSION; NUCLEAR-BODIES; LXXLL MOTIF; TRANSACTIVATION DOMAIN;
D O I
10.1128/MCB.01603-09
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Special AT-rich sequence-binding protein 1 (SATB1) is a tissue-restricted genome organizer that provides a key link between DNA loop organization, chromatin modification/remodeling, and transcription factor association at matrix attachment regions (MARs). The SUMO E3 ligase PIAS1 enhances SUMO conjugation to SATB1 lysine-744, and this modification regulates caspase-6 mediated cleavage of SATB1 at promyelocytic leukemia nuclear bodies (PML NBs). Since this regulated caspase cleavage occurs on only a subset of SATB1, and the products are relatively stable, proteolysis likely mediates cellular processes other than programmed cell death. However, the mechanism for the spatial and temporal regulation of SATB1 sumoylation and caspase cleavage is not known. Here we report that these processes are controlled by SATB1 phosphorylation; specifically, PIAS1 interaction with SATB1 is inhibited by phosphorylation. Mutagenesis studies identified interaction of the PIAS SAP (scaffold attachment factor-A/B/acinus/PIAS) motif with SATB1 N-terminal sequences. Notably, phosphorylation of SATB1 at threonine-188 regulates its interaction with PIAS1. Sequences near this phosphorylation site, LXXLL (residues 193 to 197), appear to be conserved among a subset of SUMO substrate proteins. Thus, this motif may be commonly involved in interaction with the PIAS SAP, and phosphorylation may similarly inhibit some of these substrates by preventing their interaction with the ligase.
引用
收藏
页码:2823 / 2836
页数:14
相关论文
共 50 条
  • [31] Tissue-specific nuclear architecture and gene expession regulated by SATB1
    Cai, ST
    Han, HJ
    Kohwi-Shigematsu, T
    NATURE GENETICS, 2003, 34 (01) : 42 - 51
  • [32] SATB1, senescence and senescence-related diseases
    Qi, Wenjing
    Bai, Jinping
    Wang, Ruoxi
    Zeng, Xianlu
    Zhang, Lihui
    JOURNAL OF CELLULAR PHYSIOLOGY, 2024, 239 (08)
  • [33] RELATIONSHIP BETWEEN THE METASTASIS OF PORSTATE CANCER AND SATB1
    Wang, Junqi
    INTERNATIONAL JOURNAL OF UROLOGY, 2014, 21 : A208 - A208
  • [34] SATB1 is a potential therapeutic target in intrahepatic cholangiocarcinoma
    Zhao, Z.
    Ma, J.
    Wu, K.
    Chen, L.
    Yu, J.
    Hu, W.
    Zhang, K.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2016, 18 (09): : 878 - 883
  • [35] Tetramerization of SATB1 is essential for regulating of gene expression
    Zheng, Minying
    Xing, Wancai
    Liu, Yabing
    Li, Meng
    Zhou, Hao
    MOLECULAR AND CELLULAR BIOCHEMISTRY, 2017, 430 (1-2) : 171 - 178
  • [36] SATB1 gene expression and breast cancer prognosis
    Hanker, Lars C.
    Karn, Thomas
    Mavrova-Risteska, Loreta
    Ruckhaeberle, Eugen
    Gaetje, Regine
    Holtrich, Uwe
    Kaufmann, Manfred
    Rody, Achim
    Wiegratz, Inka
    BREAST, 2011, 20 (04): : 309 - 313
  • [37] Re: The Role of SATB1 in Breast Cancer Pathogenesis
    Kohwi-Shigematsu, Terumi
    Han, Hye-Jung
    Russo, Jose
    Kohwi, Yoshinori
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2010, 102 (24) : 1879 - 1880
  • [38] Phosphorylated SATB1 is associated with the progression and prognosis of glioma
    S Han
    J Xia
    X Qin
    S Han
    A Wu
    Cell Death & Disease, 2013, 4 : e901 - e901
  • [39] Relationship between SATB1 expression and prognosis in astrocytoma
    Chu, Sheng-Hua
    Ma, Yan-Bin
    Feng, Dong-Fu
    Zhang, Hong
    Qiu, Jian-Hua
    Zhu, Zhi-An
    Li, Zhi-Qiang
    Jiang, Pu-Cha
    JOURNAL OF CLINICAL NEUROSCIENCE, 2013, 20 (04) : 543 - 547
  • [40] SATB1 is a Novel Molecular Target for Cancer Therapy
    Ding, Meng
    Pan, Jun
    Guo, Zhicheng
    Liu, Quhe
    Yang, Chunhua
    Mao, Lijun
    CANCER INVESTIGATION, 2018, 36 (01) : 28 - 36